According to DelveInsight’s analysis, the growth of the Cataract Surgery Devices Market is primarily driven by the rising prevalence of cataracts and vision impairment, increased incidence of lifestyle-related conditions contributing to cataract development, the expanding geriatric population, and accelerated product development initiatives by leading industry players.
DelveInsight’s “Cataract Surgery Devices Market Insights, Competitive Landscape and Market Forecast-2032” report provides a comprehensive view of the current and projected market, upcoming device innovations, challenges, key drivers and barriers, as well as highlights major emerging products and the companies actively shaping the market.
To explore why North America is leading growth in the Cataract Surgery Devices market, check out the report snapshot @ Cataract Surgery Devices Market Trends
Cataract Surgery Devices Overview
Cataract surgery devices are specialized medical tools used to remove a clouded natural lens and replace it with an intraocular lens (IOL) to restore vision. Key devices include phacoemulsification systems, femtosecond lasers, IOLs, and ophthalmic viscosurgical devices (OVDs), enabling precise, safe, and efficient cataract removal and lens implantation.
DelveInsight Analysis: The global cataract surgery devices market was valued at USD 8,703.96 million in 2024, projected to reach USD 12,866.16 million by 2032, registering a CAGR of 5.07% from 2025 to 2032.
Cataract Surgery Devices Market Insights
Geographically, North America is expected to dominate the market in 2024, accounting for around 39% of global share. This is driven by the increasing incidence of cataracts, aging population, and comorbidities such as diabetes and hypertension. According to NIH (2023), over 50% of U.S. adults aged 80+ either have cataracts or have undergone cataract surgery. Additionally, CDC data (2024) reported approximately 20.5 million Americans aged 40+ were living with cataracts in 2022. This large patient population is driving adoption of advanced surgical technologies that improve precision, efficiency, and outcomes.
For more details on the latest developments in Cataract Surgery Devices, view the snapshot @ Cataract Surgery Devices
Recent Developments
- April 2025: Alcon introduced the UNITY® Vitreoretinal Cataract System (VCS) and UNITY® Cataract System (CS), featuring UNITY 4D Phaco, HYPERVIT® 30K, and UNITY Intelligent Fluidics to enhance surgical precision and efficiency.
- March 2025: Alcon launched the Vivity® EDOF IOL on Clareon® lens material, receiving CE Mark approval in Europe.
- July 2024: Oertli Instrumente AG received FDA 510(k) clearance for its Faros anterior cataract surgery system, designed for cataracts, vitreoretinal procedures, and glaucoma.
- June 2024: FDA cleared Alcon’s UNITY® VCS and CS, offering improved precision for vitreoretinal cataract surgeries.
- April 2023: Bausch + Lomb launched StableVisc™ OVD and TotalVisc™ Viscoelastic System in the U.S. to aid efficient lens replacement during cataract surgery.
Key Players in the Cataract Surgery Devices Market
Some of the leading market players include:
Alcon Inc., Johnson & Johnson Services, Inc., NIDEK CO., LTD., ZEISS Group, Bausch Health Companies Inc., Ziemer Ophthalmic Systems AG, Abbott Laboratories, HOYA Corporation, Aurolab, Hanita Lenses Ltd, Topcon Corporation, STAAR SURGICAL, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc., Medisonic Equipments Pvt. Ltd., Opthalmika Ltd, Lumenis Be Ltd., Essilor International, Oertli Instrumente AG, and others.
Which MedTech leaders in the Cataract Surgery Devices market are poised to set the trends? Explore @ Key Cataract Surgery Devices Companies.
Analysis of the Cataract Surgery Devices Market Landscape
Technological innovation and new product approvals are key growth drivers. For instance, Alcon’s UNITY Cataract and VCS systems feature UNITY 4D Phaco, enhancing precision, stability, and efficiency while reducing energy usage. Expanding healthcare infrastructure in emerging regions, growing eye health awareness, and favorable reimbursement policies in developed markets are further supporting growth.
However, surgical complications such as posterior capsule opacification, cystoid macular edema, retinal detachment, and infections remain challenges to market expansion. Despite these barriers, rising prevalence of cataract-related vision impairment, supportive public health programs, and ongoing technological innovation are expected to sustain strong market growth between 2025 and 2032.
Scope of the Cataract Surgery Devices Market Report
- Coverage: Global
- Study Period: 2022–2032
- Market Segmentation by Product Type: Phacoemulsification Systems, Femtosecond Lasers, Intraocular Lenses, Viscosurgical Devices, Others
- Market Segmentation by End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
- Market Segmentation by Geography: North America, Europe, Asia-Pacific, Rest of the World
- Key Companies: Alcon, Johnson & Johnson, NIDEK, ZEISS, Bausch Health, Ziemer, Abbott, HOYA, Aurolab, Topcon, STAAR SURGICAL, Oertli, and others
- Additional Analysis: Porter’s Five Forces, Product Profiles, Case Studies, KOL Insights, Analyst Views
Click here to get a snapshot of the Cataract Surgery Devices Market Analysis
| 1 | Cataract Surgery Devices Market Report Introduction |
| 2 | Cataract Surgery Devices Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Cataract Surgery Devices Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Cataract Surgery Devices Market |
| 7 | Cataract Surgery Devices Market Layout |
| 8 | Global Company Share Analysis – Key Cataract Surgery Devices Companies |
| 9 | Company and Product Profiles |
| 10 | Project Approach |
| 11 | Cataract Surgery Devices Market Drivers |
| 12 | Cataract Surgery Devices Market Barriers |
| 13 | About DelveInsight |
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
